Rani Therapeutics Holdings, Inc. Balance Sheet
RANI|4 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Rani Therapeutics Holdings, Inc. had $59M in total assets and $33M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash & Equivalents | $18.6M | $3.8M | $27.0M | $117.5M |
| Accounts Receivable | $2.0M | - | - | - |
| Current Assets | $53.3M | $29.7M | $100.9M | $119.6M |
| PP&E (Net) | $736.0K | $1.5M | $6.0M | $4.6M |
| Total Assets | $58.6M | $36.6M | $108.0M | $124.2M |
| Current Liabilities | $12.7M | $19.9M | $4.8M | $2.6M |
| Total Debt | - | $9.6M | $29.1M | - |
| Shareholders' Equity | $33.0M | $2.0M | $36.9M | $47.4M |